A post-marketing surveillance study of Neutrolin, a novel catheter lock solution, in hemodialysis patients with tunneled central venous catheters (CVC)

Trial Profile

A post-marketing surveillance study of Neutrolin, a novel catheter lock solution, in hemodialysis patients with tunneled central venous catheters (CVC)

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 05 May 2016

At a glance

  • Drugs Citrate/heparin/taurolidine (Primary)
  • Indications Catheter infections
  • Focus Adverse reactions
  • Most Recent Events

    • 05 May 2016 According to a CorMedix media release, data (n=199) from this study were presented at the 1st Gulf Congress of Clinical Microbiology and Infectious Diseases.
    • 01 Jun 2015 According to a CorMedix media release, data from this study was presented at the European Renal Association's 52nd European Dialysis and Transplant Association (ERA-EDTA) Congress.
    • 30 Apr 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top